Citius OncologyCTOR
13F holders, Q3 2024 (September 30)7holders
$1.38avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding Citius Oncology Inc. (CTOR) in their 13F filings. The largest holders were Yakira Capital Management, Inc. ($22K), Virtu Financial LLC ($14K) and IFP Advisors, Inc ($11K).
- Company
- Citius Oncology Inc.
- CUSIP
- 17331Y109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $57K |
| Exits | 0 | $0 |
Ownership 7 holders
| Yakira Capital Management, Inc. | 0.01% | New | 15,499 | $22K |
| Virtu Financial LLC | 0.00% | New | 10,291 | $14K |
| IFP Advisors, Inc | 0.00% | New | 8,135 | $11K |
| Osaic Holdings, Inc. | 0.00% | New | 5,480 | $8K |
| UBS Group AG | 0.00% | New | 1,632 | $2K |
| Bank of America Corp. | 0.00% | New | 160 | $222 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 41 | $57 |
"% of holder's portfolio" is CTOR's weight in each manager's 13F, not the share of Citius Oncology Inc. the manager owns.